The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Diabetologia · 2023-10 · 66 (10) · 1846-1858
DOI: 10.1007/s00125-023-05966-9 ↗At a glance
Übersichtsarbeit in Diabetologia, published online on 2023-07-27. Written by Christine R Andreasen and 2 co-authors. Institution: Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2. Cited 43 times so far (Crossref); 101 references.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
- Clinical Research, Copenhagen University Hospital - Steno Diabetes Center Copenhagen, Herlev, Denmark. t.vilsboll@dadlnet.dk.
- Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. t.vilsboll@dadlnet.dk.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. t.vilsboll@dadlnet.dk.
Cite
APA
Andreasen, C. R., Andersen, A., & Vilsbøll, T. (2023). The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Diabetologia, 66(10), 1846-1858. https://doi.org/10.1007/s00125-023-05966-9
Vancouver
Andreasen CR, Andersen A, Vilsbøll T. The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease. Diabetologia. 2023;66(10):1846-1858. doi:10.1007/s00125-023-05966-9
BibTeX
@article{Andreasen2023,
author = {Andreasen, Christine R and Andersen, Andreas and Vilsbøll, Tina},
title = {The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease},
journal = {Diabetologia},
year = {2023},
volume = {66},
number = {10},
pages = {1846--1858},
doi = {10.1007/s00125-023-05966-9}
}
EUVIMED